Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corsini

Showing results (11-20 of 1,909) with videos related to

Pageof 191
Sort By:
Drugs|August 5, 2011
Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differencesRoberta Baetta, Alberto Corsini
Current Medical Research and Opinion|June 21, 2011
Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?Alberto Corsini, Richard Ceska
Current Protocols in Toxicology|November 22, 2012
The NCTC 2544 IL-18 assay for the in vitro identification of contact allergensValentina Galbiati, Emanuela Corsini
Giornale Italiano Di Cardiologia (2006)|December 24, 2014
[Role of secreted and lipoprotein-associated phospholipase A2 in cardiovascular risk]Nicola Ferri, Alberto Corsini
Giornale Italiano Di Cardiologia (2006)|February 3, 2025
[Clinical pharmacology of combination therapies for the prevention and treatment of cardiovascular diseases]Nicola Ferri, Alberto Corsini
Current Atherosclerosis Reports|June 5, 2020
Clinical Pharmacology of Statins: an UpdateNicola Ferri, Alberto Corsini
Giornale Italiano Di Cardiologia (2006)|April 13, 2021
[Bempedoic acid: mechanism of action]Alberto Corsini, Pietro Scicchitano
Atherosclerosis. Supplements|January 11, 2015
Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatinLorenzo Arnaboldi, Alberto Corsini
Biomolecular NMR Assignments|July 29, 2009
Backbone assignment of the UHM domain of Puf60 free and bound to five ligandsLorenzo Corsini, Michael Sattler
European Journal of Internal Medicine|September 7, 2010
Reversible and non-reversible cardiovascular risk in patients treated with lipid-lowering therapy: analysis of SEAS and JUPITER trialsA Poli, A Corsini
Pageof 191

Showing results (11-20 of 1,909) with videos related to

Sort By:
Pageof 191
Drugs|August 5, 2011
Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differencesRoberta Baetta, Alberto Corsini
Current Medical Research and Opinion|June 21, 2011
Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?Alberto Corsini, Richard Ceska
Current Protocols in Toxicology|November 22, 2012
The NCTC 2544 IL-18 assay for the in vitro identification of contact allergensValentina Galbiati, Emanuela Corsini
Giornale Italiano Di Cardiologia (2006)|December 24, 2014
[Role of secreted and lipoprotein-associated phospholipase A2 in cardiovascular risk]Nicola Ferri, Alberto Corsini
Giornale Italiano Di Cardiologia (2006)|February 3, 2025
[Clinical pharmacology of combination therapies for the prevention and treatment of cardiovascular diseases]Nicola Ferri, Alberto Corsini
Current Atherosclerosis Reports|June 5, 2020
Clinical Pharmacology of Statins: an UpdateNicola Ferri, Alberto Corsini
Giornale Italiano Di Cardiologia (2006)|April 13, 2021
[Bempedoic acid: mechanism of action]Alberto Corsini, Pietro Scicchitano
Atherosclerosis. Supplements|January 11, 2015
Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatinLorenzo Arnaboldi, Alberto Corsini
Biomolecular NMR Assignments|July 29, 2009
Backbone assignment of the UHM domain of Puf60 free and bound to five ligandsLorenzo Corsini, Michael Sattler
European Journal of Internal Medicine|September 7, 2010
Reversible and non-reversible cardiovascular risk in patients treated with lipid-lowering therapy: analysis of SEAS and JUPITER trialsA Poli, A Corsini
Pageof 191